435 related articles for article (PubMed ID: 11650285)
1. A new problem for IRBs: screening for HIV antibodies.
Meyers K
IRB; 1989; 11(6):10-1. PubMed ID: 11650285
[No Abstract] [Full Text] [Related]
2. Applying "an ethical framework" to a proposed HIV antibody screening program.
Meyers K; Dunton AW
IRB; 1988; 10(1):6-8. PubMed ID: 11658989
[No Abstract] [Full Text] [Related]
3. Guidelines for confidentiality in research on AIDS.
Bayer R; Levine C; Murray TH
IRB; 1984; 6(6):1-7. PubMed ID: 11649192
[No Abstract] [Full Text] [Related]
4. Hyperbaric research at Duke University--ethical considerations.
Bennett PB; Kylstra JA
Forsvarsmedicin; 1973; 9(3):373-8. PubMed ID: 11661280
[No Abstract] [Full Text] [Related]
5. Guidelines for conducting HIV research with human subjects at a U.S. military medical center.
Marks ES; Derderian SS; Wray HL
IRB; 1992; 14(1):7-10. PubMed ID: 11652042
[No Abstract] [Full Text] [Related]
6. Structuring the review of human genetics protocols, Part II: diagnostic and screening studies.
Glass KC; Weijer C; Lemmens T; Palmour RM; Shapiro SH
IRB; 1997; 19(3-4):1-13. PubMed ID: 11656943
[No Abstract] [Full Text] [Related]
7. A protocol review guide to reduce IRB inconsistency.
Prentice ED; Antonson DL
IRB; 1987; 9(1):9-11. PubMed ID: 11649892
[No Abstract] [Full Text] [Related]
8. Pharmacological and psychological research on AIDS: some ethical considerations.
Perry SW
IRB; 1987; 9(5):8-10. PubMed ID: 11649899
[No Abstract] [Full Text] [Related]
9. Health Sciences Council of Japan adopts guidelines for gene therapy clinical research.
Int Dig Health Legis; 1995; 46(4):560-3. PubMed ID: 11657358
[No Abstract] [Full Text] [Related]
10. A case study in adolescent participation in clinical research: eleven clinical sites, one common protocol, and eleven IRBs.
Rogers AS; Schwartz DF; Weissman G; English A;
IRB; 1999; 21(1):6-10. PubMed ID: 11657967
[No Abstract] [Full Text] [Related]
11. Perspectives of protocol reviewers.
Moline ML; Aisen MW
J Calif Alliance Ment Ill; 1994; 5(1):59-60. PubMed ID: 11653327
[No Abstract] [Full Text] [Related]
12. Judging the ethical merit of clinical trials: what criteria do research ethics board members use?
Meslin EM; Lavery JV; Sutherland HJ; Till JE
IRB; 1994; 16(4):6-10. PubMed ID: 11654136
[No Abstract] [Full Text] [Related]
13. Protocol review within the context of a research program.
Miller FG; Rosenstein DL
IRB; 1998; 20(4):7-10. PubMed ID: 11657088
[No Abstract] [Full Text] [Related]
14. Ethics of clinical trials for research ethics boards: proceedings of a national workshop.
National Council on Bioethics in Human Research (Canada)
NCBHR Commun; 1991; 2(2):4-23. PubMed ID: 11659919
[No Abstract] [Full Text] [Related]
15. Against special protections for medical students.
Angoff NR
IRB; 1985; 7(5):9-10. PubMed ID: 11649754
[No Abstract] [Full Text] [Related]
16. AIDS prevention among IV drug users: potential conflicts between research design and ethics.
Des Jarlais DC; Friedman SR
IRB; 1987; 9(1):6-8. PubMed ID: 11649891
[No Abstract] [Full Text] [Related]
17. Human experimentation: the review process in practice.
Cowan DH
Case West Reserve Law Rev; 1975; 25(3):533-64. PubMed ID: 11661165
[No Abstract] [Full Text] [Related]
18. Sharing scientific data I: new problems for IRBs.
Sieber JE
IRB; 1989; 11(6):4-7. PubMed ID: 11650286
[No Abstract] [Full Text] [Related]
19. Do medical student research subjects need special protection?
Christakis N
IRB; 1985; 7(3):1-4. PubMed ID: 11649647
[No Abstract] [Full Text] [Related]
20. Ethical issues in research design and conduct: developing a test to detect carriers of Huntington's disease.
MacKay CR
IRB; 1984; 6(4):1-5. PubMed ID: 11649560
[No Abstract] [Full Text] [Related]
[Next] [New Search]